首页 | 本学科首页   官方微博 | 高级检索  
     


Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma
Authors:Firas Baidoun  Zahi Merjaneh  Fatma Abd-Elshahed Abd-Elhay  Mohamed Gomaa Kamel
Affiliation:1. Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, OH 44145, United States;2. Faculty of Medicine, Minia University, Minia, Egypt
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号